Targeted Cancer Therapy Market to Reach US$ 175.48 Billion by 2035 Driven by Precision Oncology Adoption, ADC Innovation, and Regulatory Productivity Says Ast…

The market holds massive commercial potential driven by superior clinical outcomes. With ADCs and radioligands leading ...
MarketWatch

PSMA-Targeted Therapy Market Set to Expand by 2034 on Strong Pipeline and Increasing Diagnosis Rates | DelveInsight

The PSMA-targeted therapy market is expected to grow strongly, fueled by higher prostate cancer diagnosis rates, improved awareness of PSMA-based treatments, and an expanding clinical trial landscape ...
Soap Central

Who is Dr. Mariano Barbacid? Spanish oncologist and his team achieve pancreatic cancer regression after targeted combination therapy

According to CNIO, among the various kinds of cancer, pancreatic cancer remains one of the deadliest and is a widely known ...
Cure Today

Targeted Ablation Therapy Improves Quality of Life in Pancreatic Cancer

Autonomix's targeted ablation therapy improved symptoms, functionality, and quality of life in severe pancreatic cancer patients, especially those with stage 4 disease. Rapid pain relief and durable ...
Cure Today

Dual-Targeting CAR T Therapy Shows Potential in Advanced Kidney Cancer

CAR T-cell therapy is being adapted for clear cell renal cell carcinoma, targeting CAIX and CD70 to improve efficacy and safety. Early trials like COBALT-RCC and TRAVERSE show promising disease ...